0001123292-20-000973.txt : 20200707
0001123292-20-000973.hdr.sgml : 20200707
20200707174114
ACCESSION NUMBER: 0001123292-20-000973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200707
FILED AS OF DATE: 20200707
DATE AS OF CHANGE: 20200707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KDev Investments AB
CENTRAL INDEX KEY: 0001789888
STATE OF INCORPORATION: V7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 201016780
BUSINESS ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
BUSINESS PHONE: 08-524 860 70
MAIL ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karolinska Development AB
CENTRAL INDEX KEY: 0001789932
STATE OF INCORPORATION: V7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 201016781
BUSINESS ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
BUSINESS PHONE: 08-524 860 70
MAIL ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KCIF Co-Investment Fund KB
CENTRAL INDEX KEY: 0001789966
STATE OF INCORPORATION: V7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 201016782
BUSINESS ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
BUSINESS PHONE: 08-524 860 70
MAIL ADDRESS:
STREET 1: TOMTEBODAVAGEN 23A
CITY: SOLNA
STATE: V7
ZIP: SE 171 65
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-07-07
1
0001781983
Aprea Therapeutics, Inc.
APRE
0001789888
KDev Investments AB
TOMTEBODAVAGEN 23A
SOLNA
V7
SE-17165
SWEDEN
0
0
1
0
0001789932
Karolinska Development AB
TOMTEBODAVAGEN 23A
SOLNA
V7
SE-17165
SWEDEN
0
0
1
0
0001789966
KCIF Co-Investment Fund KB
TOMTEBODAVAGEN 23A
SOLNA
V7
SE-17165
SWEDEN
0
0
1
0
Common Stock
2020-07-07
4
S
0
241703
34.55
D
1992586
I
See Footnote
The amount of securities of Aprea Therapeutics, Inc. (the "Issuer") reported as beneficially owned includes shares held of record by: KDev Investments AB, Karolinska Development AB and KCIF Co-Investment Fund KB (collectively, the "Reporting Persons").
Karolinska Development AB ("Karolinska") is the majority owner and co-manager of KDev Investments AB and a limited partner of KCIF Co-Investment Fund KB. Karolinska and each of the other Reporting Persons disclaim beneficial ownership of any shares of the Issuer's Common Stock owned of record by any of the other Reporting Persons except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that any such entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The address of each of (i) KDev Investments AB, (ii) Karolinska Development AB, and (iii) KCIF Co-Investment Fund KB is Tomtebodavagen 23A, SE 171 65 Solna, Sweden.
KDev Investments AB By: /s/ Viktor Drvota
2020-07-07
Karolinska Development AB By: /s/ Viktor Drvota
2020-07-07
KCIF Co-Investment Fund KB By: /s/ Fredrik Jarrsten, attorney-in-fact
2020-07-07